Gen-Next Probiotics & Microbiome Congress: Major Breakthroughs, Challenges, and Potential Research Areas - 2-Day Event in San Diego, CA, United States - February 6-7, 2020
DUBLIN, Dec. 30, 2019 /PRNewswire/ -- The "Gen-Next Probiotics and Microbiome Congress" conference has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
What are the essentials being missed out on?
Witness the major breakthroughs of microbial research and application pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners. The intersection between emerging technology and discovery with the context of consumer interest. Detect the non-identified dysbiosis, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery.
-- Major breakthroughs of microbial research and applications
-- Challenges associated with medicinal data interpretation, investments
and regulatory hurdles
-- Detection of non-identified dysbiosis to discover potential research
areas with increasing investments in gut and skin microbiome
Join us at Gen-Next Probiotics and Microbiome Congress, 2020 to network with biotech, pharma, academicians and investors to exchange views and observe the most ingenious research and technologies. Understand what's happening. Witness the amalgamation of study focused on pharmaceutical and medicinal approaches of probiotics and the nutraceutical and consumer approaches along with the role of microbiome in clinical applications and preventative medicine.
Key Highlights
-- Microbial Innovations
-- Gut and Skin Microbiota
-- Regulatory Issues
-- Live Probiotic Technology
-- Strain Identification
-- Fecal Microbiota & Engineered Microbiome
-- Commercialization and Marketing
Who Should Attend?
Directors, Heads, Professors/Assistant Professors/Associate Professor, Research Scholars, Scientists from the departments of:
-- Microbiome discovery
-- Microbiome science
-- Microbiology
-- Human microbiome
-- Drug discovery
-- Therapeutics
-- Immunotherapy
-- Microbiology
-- Microbiome therapeutics
-- Microbiome
-- Gastroenterology
-- Immunology
-- Bioinformatics
-- Obstetrics
-- Neonatology
-- Pediatrics
-- Nutritionists/dieticians
Agenda
Day 1
07:55 - 08:55 Registration
08:55 - 09:00 Opening note
09:00 - 09:05 Opening remarks by Chairman
09:05 - 09:35 Keynote presentation
Emerging Trends in Microbiome
09:35 - 10:05 Microbiome in Preventative medicine- Pave the way towards Future and Beyond
10:05 - 10:35 Solution provider presentation
10:35 - 11:25 Morning refreshment and Networking
11:25 - 11:55 Use of Supply chain to produce treatments developed through live bacteria
11:55 - 12:25 Potential Role of Next-Generation Sequencing in Disease Diagnosis and Treatment
12:25 - 12:55 Solution provider presentation
12:55 - 13:55 Lunch and Networking
Developments in Microbiome Therapeutics
13:55 - 14:25 Rising Developments in Microbiome and Microglia Research: Implications for Neurodevelopmental Disorders
14:25 - 14:55 The Human Microbiome: A New Protagonist in managing Human Health
14:55 - 15:25 Solution provider presentation
15:25 - 15:55 Afternoon Refreshments and Networking
15:55 - 16:25 Panel Discussion: Microbiome therapeutics - just publicity or is it occurring?
16:25 - 16:55 Gut Microbiota and Cancer: From Pathogenesis to Therapy
16:55 - 17:25 Impact of the microbiome in the gut-brain axis
17:30 - 18:30 Drink Reception & Networking
Day 2
08:30 - 08:55 Registration
Clinical Application of Microbiome
09:05 - 09:35 Microbiome - A diagnostic tool of pharmaceutical R&D and discovery
09:35 - 10:05 Role of Skin Microbiota in cutaneous health and disease
10:05 - 10:35 Solution provider presentation
10:35 - 11:25 Morning refreshment and Networking
11:25 - 12:05 Panel Discussion: State of current Innovation and Future integration of microbiome-based approaches into Routine oncology practice
12:05 - 12:40 Clinical and preclinical trials result in immune-checkpoint and microbiome
12:40 - 13:10 Solution provider presentation
13:10 - 14:10 Lunch Break and Networking
Funding and Regulatory Hurdles
14:10 - 14:40 Working on 3 I's for success- Developing an IP strategy for attracting Insurers and Investors
14:40 - 15:10 Impact of current regulatory body on microbiome-based therapies
15:10 - 15:40 FDA in anticancer novel probiotics- A systematic overview
15:40 - 16:10 Emerging FDA regulations: Understanding the microbiome-based product regulations
Speakers
-- David Kyle, Executive Chairman and CSO, Evolve BioSystems, Inc
-- Masi Rajabi, Director of Microbiology, Nephron Pharmaceuticals
-- Dawn Bowdish, Assistant Professor, McMaster University
-- Maya Ivanjesku, Chief Scientific Officer, Dakota Biotech
-- Shailendra Singh (Shelly), Chief Operating Officer, MarketsandMarkets
-- Bharath Prithiviraj, Senior Scientist, Prime Discoveries
-- Ross Youngs, CEO & Founder, Biosortia Pharmaceuticals
-- Seth Crosby, Director, Research Collaborations, Washington University
School of Medicine
-- Elliot Friedman, Senior Research Investigator, University of
Pennsylvania
-- Peter Leighton, CEO, ProSperity Bioscience
-- Tal Korem, Assistant Professor, Columbia University
-- Chuck Collins, Professor, East Tennessee State University
-- Joseph C Ellis, Sr. Staff Scientist, OAK Ridge National Laboratory
-- Aubrey Levitt, CEO/Co-Founder, Postbiotics+
-- M. Andrea Azcarate-Peril, Director, Microbiome Core Facility, University
of North Carolina
-- Arun Bhunia, Professor of Food Microbiology, Purdue University
-- A. Bruce Johnson, PhD, Corporate Vice President, Business Development,
Animal Health Corporation
For more information about this conference visit https://www.researchandmarkets.com/r/yilusb
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
